Journal of Biological Chemistry · 2004 · 67 citations · 20 references
Life SciencesGeneticsNeuroscienceMolecular NeuroscienceNeurodegenerationNeurogeneticsApoptosis In NeurodegenerationMolecular Basis Of NeurodegenerationNeurodegenerative DiseasesNeurodegenerative DisordersNeurogenetic DisordersSpinocerebellar AtaxiasAutosomal Dominant AtaxiaHek293 Cell ExpressionHereditary AtaxiasLoss-of-function EffectsLoss-of-function MutationsPrimary CellsRepeat Expansion MutationsSpinocerebellar Ataxia Genetics
Spinocerebellar ataxia (SCA) type 10, an autosomal dominant disease characterized by cerebellar ataxia, is caused by a novel pentanucleotide (ATTCT) repeat expansion in the SCA10 gene. Although clinical features of the disease are well characterized, nothing is known so far about the affected SCA10 gene product, ataxin-10 (Atx-10). We have cloned the rat SCA10 gene and expressed the corresponding protein in HEK293 cells. Atx-10 has an apparent molecular mass of approximately 55 kDa and belongs to the family of armadillo repeat proteins. In solution, it tends to form homotrimeric complexes, which associate via a tip-to-tip contact with the concave sides of the molecules facing each other. Atx-10 immunostaining of mouse and human brain sections revealed a predominantly cytoplasmic and perinuclear localization with a clear restriction to olivocerebellar regions. Knock down of SCA10 in primary neuronal cells by small interfering RNAs resulted in an increased apoptosis of cerebellar neurons, arguing for a loss-of-function phenotype in SCA10 patients.
20
Miguel Ángel Gutiérrez Andrade, Pablo Chacón, J. J. Merelo et al. · Protein Engineering Design and Selection · 1993 · 1K citations
Regulation of Mitochondrial Iron Accumulation by Yfh1p, a Putative Homolog of Frataxin
Michael Babcock, Deepika de Silva, Robert Oaks et al. · Science · 1997 · 919 citations